Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-25-220848

Chief Legal Officer sold 11,278 shares at $9.77 ($110,186)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-25 Sale : show line 1 in the form 10b5-1 −11,278 $9.77 $110,186 293,852 D
Open-market sales · 11,278 sh · avg $9.77 · $110,186
Loading xslF345X05/ownership.xml…